Phone icon(913) 262 1436 emailIconEmail Us

CDC Recommends HPV Vaccine for Boys

A federal government advisory committee voted Tuesday to recommend that males ages 11 to 21 be vaccinated against the human papilloma virus, which is blamed for thousands of cases of cancer among women and men.

(Full Story)

Top

Prebook GSK Flu Vaccines Now

Effective immediately, the Child Health Advantage Program has signed a GSK Influenza Vaccine agreement for the 2014-2015 flu season. This agreement provides participants in the Child Health Advantage Program with the ability to pre-book flu vaccine at contracted rates. Pre-booking is available until March 31, 2014. Highlights are listed below. Please contact us for more information.

2014-2015 GSK Pre-book Influenza Pricing

NDC

Product Description

Contract Price1

Discounted Price (2% flu advantage, 2% prompt pay)

58160-0901-52

FLUARIX QUADRIVALENT 0.5 ML Tip-Lok No Needle Syringes 10s (=3 years of age)

$150.00

$144.10

19515-0894-52

FLULAVAL QUADRIVALENT 0.5 ML Tip-Lok No Needle Syringes 10s (=3 years of age)

$150.00

$144.10

58160-0881-52

FLUARIX TRIVALENT 0.5 ML Tip-Lok No Needle Syringes 10s (=3 years of age)

$97.50

$93.60

19515-0891-11

FLULAVAL QUADRIVALENT 5 ML Multi-dose Vials 10s (=3 years of age)

$140.10

$134.60

19515-0893-07

FLULAVAL TRIVALENT 5 ML Multi-dose Vials 10s (=3 years of age)

$68.30

$65.57

1Price for Fluarix®/FluLaval® does not include the Federal Excise Tax of $0.75 per antigen, per dose.

Agreement Highlights:

  • Ordering

    • Pre-booking for the 2014-2015 flu season runs through March 31, 2014.
    • Order must be placed via www.gskvaccinesdirect.com or authorized GSK Influenza Vaccine distributors.
  • Delivery

    • GSK anticipates shipments of GSK Influenza Vaccines to begin in August 2014. (Subject to Availability)
    • Delivery Schedule: Total prebooked doses to be shipped by September 30, 2014.
    • Delivery Guarantee: Pre-booked orders shipped and invoiced after September 30, 2014 will receive an additional 10% discount.
  • Returns

    • In addition to GSK Influenza Vaccine doses returned in accordance with GSK’s returned goods policy as posted on www.gskvaccinesdirect.com, members will be eligible to return up to 30% of their Influenza Vaccine does pre-booked on or prior to March 31, 2014 by June 30, 2015.

Changes From Last Year:

  • No Minimum Dose Requirement: GSK is not requiring minimum number of doses to be eligible for prebook this year.
  • Lower Flu Advantage Discount: Prebooked doses through www.gskvaccinesdirect.com will be discounted by 2% rather than last year’s 3%.
  • Higher Return Rate: Members may return up to 30% of their doses, or 5% more than last year.
  • Order Through GSK Direct Only: Discounts, guarantees, and returns only apply to product ordered directly through GSK. Orders placed with a GSK authorized distributor will be subject to distributor’s terms and conditions.

If you have any questions regarding this offer, please feel free to contact any member of the Child Health Advantage Team.

Top

Menveo Available through Novartis Direct

Novartis is prepared for back-to-school demand for Menveo.

Top

GSK offers Up Front Pricing to Eligible Members

GlaxoSmithKline (GSK) has started offering up front pricing to members who meet certain performance requirements. Members can now receive the lowest possible purchase price on GSK vaccines without having to wait for a rebate. To see if you qualify for this program, please contact a member of the Child Health Advantage team.

Top

GSK to Accept and Fulfill Orders for Menveo

Beginning March 1, 2013, GlaxoSmithKline (GSK) will accept and fulfill orders for the Menveo vaccine manufactured by Novartis. This agreement will allow participants in the Child Health Advantage Program continued access to Menveo and will be included as part of the GSK agreement. If you have any questions regarding this offer, please feel free to contact any member of the Child Health Advantage Team.

Top

Pre-Book GSK Flu Vaccines Now

Effective immediately, Child Health Advantage members are able to pre-book Fluarix and Flulaval for the 2013-2014 flu season. Pre-booking is available until March 31, 2013.

Agreement Highlights:

  • Ordering
    • Pre-booking for the 2013-2014 flu season is from January 15, 2013-March 31, 2013
    • Order must be placed via www.gskvaccinesdirect.com or authorized GSK Influenza Vaccine distributors.
  • Delivery
    • GSK anticipates shipments of GSK Influenza Vaccines to begin in August 2013. (Subject to Availability)
    • Delivery Schedule: Partial shipments totaling 50% of doses ordered by September 15, 2013 with the balance to be complete by October 15, 2013.
    • Delivery Guarantee: Pre-booked orders shipped and invoiced after October 15, 2013 will receive an additional 10% discount.
  • Returns
    • In addition to GSK Influenza Vaccine doses returned in accordance with GSK’s returned goods policy as posted on www.gskvaccinesdirect.com, members will be eligible to return up to 25% of their Influenza Vaccine does pre-booked on or prior to March 31, 2013 by June 1, 2014.

If you have any questions regarding this offer, please feel free to contact any member of the Child Health Advantage Team.

Top

Menveo Vaccine Fall Promotion

Purchase up to 250 doses of MenveoR and pay only $81.37* per dose.

For Split shipments :

  • Call Novartis Vaccines Customer Service at 877-NV-DIRECT (877-683-4732) to place first order.
  • Second shipment must be received by December 15, 2011.
  • Child Health Advantage (CHA) Members enter FALLPROMO as your Group Number when ordering.
  • RabAvertR (Rabies Vaccine)

Not a CHA Member? Contact us to get signed up.

*Price does not include tax.

To receive this price on more than 250 doses, prior approval is needed. Contact your Novartis representative.

Top

Best Price in the Nation on Menveo

As of April 1, 2011, Child Health Advantage Members receive discounts up to 15% on Novartis' Menveo vaccine.

(Link to more info)

Top

FDA approves Menveo vaccine

Novartis Receives Additional Approval for Menveo Vaccine

Novartis (Basel, Switzerland) received approval from the FDA (Silver Spring, MD) for the use of Menveo (Meningococcal [Groups A, C, Y and W-135] Oligosaccharide Diphtheria CRM197 Conjugate Vaccine) for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in individuals two to 10 years of age. The company received initial FDA approval in 2010 for use of Menveo in adolescents and adults from 11 to 55 years of age.
(Read the full story).

Top

New Vaccination Recommendations

The AAP's new vaccination recommendations target meningitis and whooping cough.

Teenagers need a booster shot to protect them from meningococcal meningitis, a potentially deadly infection of the tissue around the brain, while all kids should have up-todate whooping cough vaccines in light of recent outbreaks, according to new recommendations from pediatric experts.

The American Academy of Pediatrics issues updated vaccination guidelines annually. Its new schedule, released Feb. 1 in the journal Pediatrics, is very similar to last year's recommendations.

(Link to Complete Article).

Top

LATEST NEWS
SIGN UP NOW
signup
OUR MISSION The Mission of Child Health Advantage is to provide community physicians with easy access to appropriate product portfolios, contract pricing, and robust distribution.